NCT06467591Completed
Prediction Model for Advanced Gastric Cancer in Elderly
Prediction of Long-term Survival and Chemotherapy Benefit in Elderly Advanced Gastric Cancer Patients Based on the mCNS Model of Nutritional Control State Score and Sarcopenia.
Source: ClinicalTrials.gov · Last updated 21 Jun 2024
Brief summary (registry, in English)
This study aims to develop and validate a Nomogram (mCNS) model for predicting long-term survival in elderly patients following curative resection for advanced gastric cancer. The study is a retrospective multi-center analysis involving 924 gastric cancer patients treated at the Department of Gastrointestinal Surgery of the Affiliated Union Hospital of Fujian Medical University between 2009 and 2013, and 512 patients aged 65 and above who underwent gastric resection at the Affiliated Zhongshan Hospital of Dalian University between 2011 and 2018. An online prognostic tool is introduced to assist clinicians in predicting patient prognosis and customizing treatment and follow-up strategies.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1436 (actual)
- First submitted
- 15 Jun 2024
- Start date
- 1 Jan 2024
- Primary completion date
- 1 May 2024
- Lead sponsor
- Chang-Ming Huang, Prof.
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06467591
What you commit to
- Study type: Observational
- Participants enrolled: 1436
- From 1 Jan 2024 to the primary completion date, 1 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Presence of peritoneal or distant metastasis confirmed before or during surgery;
- Received neoadjuvant chemotherapy before surgery;
- Emergency surgery or palliative exploratory surgery;
Other illness
- Remnant gastric cancer;
Age
- Age \< 65 years;
Other
- Pathological stage T1 and T2N0;
- Preoperative abdominal CT scan not available or preoperative examination time \> 1 month;
- Survival time less than 1 month;
- Incomplete clinical and pathological data.
Who the study is looking for
- Confirmed as primary gastric adenocarcinoma by preoperative gastric endoscopy pathology;
- Underwent R0 laparoscopic radical gastrectomy for gastric cancer;
- Pathological stage T2-4a-N+;
- Age ≥ 65 years.
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Gastric Surgery， Fujian Medical University Union Hospital Coordinator of this site? Confirm its status | Fuzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.